Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A role for TNF-α in alveolar macrophage damage-associated molecular pattern release
Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee
Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee
View: Text | PDF
Research Article Immunology

A role for TNF-α in alveolar macrophage damage-associated molecular pattern release

  • Text
  • PDF
Abstract

Chronic beryllium disease (CBD) is a metal hypersensitivity/autoimmune disease in which damage-associated molecular patterns (DAMPs) promote a break in T cell tolerance and expansion of Be2+/self-peptide–reactive CD4+ T cells. In this study, we investigated the mechanism of cell death induced by beryllium particles in alveolar macrophages (AMs) and its impact on DAMP release. We found that phagocytosis of Be led to AM cell death independent of caspase, receptor-interacting protein kinases 1 and 3, or ROS activity. Before cell death, Be-exposed AMs secreted TNF-α that boosted intracellular stores of IL-1α followed by caspase-8–dependent fragmentation of DNA. IL-1α and nucleosomal DNA were subsequently released from AMs upon loss of plasma membrane integrity. In contrast, necrotic AMs released only unfragmented DNA and necroptotic AMs released only IL-1α. In mice exposed to Be, TNF-α promoted release of DAMPs and was required for the mobilization of immunogenic DCs, the expansion of Be-reactive CD4+ T cells, and pulmonary inflammation in a mouse model of CBD. Thus, early autocrine effects of particle-induced TNF-α on AMs led to a break in peripheral tolerance. This potentially novel mechanism may underlie the known relationship between fine particle inhalation, TNF-α, and loss of peripheral tolerance in T cell–mediated autoimmune disease and hypersensitivities.

Authors

Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee

×

Figure 4

TNF-α promotes release of DNA from Be-exposed AMs by activating caspase-8.

Options: View larger image (or click on image) Download as PowerPoint
TNF-α promotes release of DNA from Be-exposed AMs by activating caspase-...
(A) Gel electrophoresis of DNA extracted from HK AMs or AMs exposed to Be for 5 hours is shown. Numbers indicate bp as determined by the DNA ladder. Data are from 1 representative of 3 independent experiments. (B) AMs from B6 mice were cultured for 10 hours in media ± 50 μg/mL Be or 100 μM etoposide (Etop). Ten hours was chosen because we could detect caspase-8 activation with both stimuli at this time. The percentage of AMs positive for caspase-8 or caspase-9 activity is shown. (C) B6 AMs were incubated with 10 μg/mL isotype control or blocking antibodies for TNFR1 (anti-TR1) or TNFR2 (anti-TR2) in media with Vehicle (Veh) or 20 μM Z-VAD-FMK (Z-VAD) for 30 minutes. The cells were then stimulated ± 50 μg/mL Be for 10 hours. Data are expressed as percentage inhibition of Be-induced caspase activity. (D) B6 AMs were pretreated with vehicle (V), 10 μM caspase-1, 10 μM caspase-3, 20 μM caspase-8, or 10 μM caspase-9 inhibitors followed by stimulation ± 50 μg/mL Be for 18 hours. Concentrations of DNA in SNs are shown for each treatment group. Graphs contain data combined from 3 independent experiments. Symbols on dot plot graphs are experimental mean values; bars indicate the mean ± SEM. Treatments for vitro AM assays (B–D) were performed in duplicate/experiment using separate cohorts of mice as sources of AMs. One-way ANOVAs (B–D) were used to test for differences between groups. P values for selected comparisons are indicated as *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts